BioSpace News Archive

The meeting was held in conjunction with the State visit of Prime Minister May.

The novel liquid handling technology has been developed to provide researchers with a standard platform whereby they can easily develop complex assays and screen them in a robust and cost efficient manner.

Zoetis Inc. (NYSE:ZTS), the leading global animal health company, today celebrated its fifth anniversary since becoming a public company by hosting U.S. Secretary of Agriculture Sonny Perdue and Governor Rick Snyder of Michigan for a special town hall meeting at the company’s global research and development headquarters in Kalamazoo, Mich.

Leading immunoassay development and manufacturing specialist BBI Solutions has marked a successful first year since the launch of the landmark Morffi signal enhancement technology.

CANbridge Life Sciences announced today that it has licensed the exclusive rights to develop and commercialize NERLYNX (neratinib) in China, Taiwan, Hong Kong and Macao (collectively, greater China) from Puma Biotechnology.

sterna today announces its participation in the following key scientific and partnering conferences in the first half of 2018.

Actinium Pharma announced today that its abstract has been accepted for a poster presentation at the 2018 American Association for Cancer Research Annual Meeting being held April 14-18, 2018 in Chicago, Illinois.

NH-ISAC is pleased to announce it has merged with SAFE-BioPharma Association as of January 1, 2018.

The sale includes Cardinal Health’s pharmaceutical and medical products distribution business in China.

PharmAbcine’s lead candidate TTAC-0001, an investigational therapy, is a highly selective and potent anti-VEGFR2 (KDR/flk-1) mAb in clinical development for rGBM indications.